Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

757.00p
   
  • Change Today:
      21.00p
  • 52 Week High: 853.00
  • 52 Week Low: 400.00
  • Currency: UK Pounds
  • Shares Issued: 82.05m
  • Volume: 103,180
  • Market Cap: £621.10m
  • RiskGrade: 291

Liberum hikes target price on Oxford Biomedica

By Iain Gilbert

Date: Tuesday 28 Apr 2020

LONDON (ShareCast) - (Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

Liberum said Oxford Biomedica had made "enormous progress" since its initiation of coverage in 2019, highlighting the completion of the new OxBox manufacturing facility for having already unlocked demand for future capacity.

The broker stated that with Oxford Biomedica now working in collaboration with the Jenner Institute consortium as a manufacturing partner for its potential Covid-19 vaccine, while it was "too early to estimate its potential", the move still represented a 12-month upside option.

Liberum also pointed out that late last year, Novartis extended its vector collaboration with the group, and in March, Juno Therapeutics chose OXB as its vector partner.

In addition to upping its price target on the group, Liberum also reiterated its 'buy' rating on OXB.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 757.00p
Change Today 21.00p
% Change 2.85 %
52 Week High 853.00
52 Week Low 400.00
Volume 103,180
Shares Issued 82.05m
Market Cap £621.10m
RiskGrade 291

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.16% below the market average30.16% below the market average30.16% below the market average30.16% below the market average30.16% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
53.50% above the market average53.50% above the market average53.50% above the market average53.50% above the market average53.50% above the market average
8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average
Income Not Available
Growth
16.38% above the market average16.38% above the market average16.38% above the market average16.38% above the market average16.38% above the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 03-Jul-2020

Time Volume / Share Price
16:35 17,428 @ 757.00p
16:29 204 @ 768.00p
16:29 14 @ 772.00p
16:29 170 @ 772.00p
16:29 44 @ 772.00p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page